Clinical Trial Update: Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome [Phase 3]

View source ↗

Summary

Phase III trial of NPB-01 for Guillain-Barré Syndrome has completed. No results are detailed in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guillain-barré Syndrome

Drugs mentioned

• NPB-01

Snippet

Sponsor: Nihon Pharmaceutical Co., Ltd | Conditions: Guillain-Barré Syndrome | Phase 3 | Status: COMPLETED